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1. Introduction 
Bacteria have been evolving in our planet for 3 500 – 4 000 million years; thus, based on 
chemical signals microbial communities have developed different systems to interact with 
their own colonies and with other species, even with host like plants or animals. Antibiotics 
release is one of the most outstanding microorganism behaviour. Microbial interaction in 
nature shows an unexpected performance, sublethal concentrations of antibiotics can 
modulate dynamic among microorganisms and it can achieve the activation of cooperation, 
self defence or motility mechanisms among microorganisms (Ratcliff & Denison, 2011).  
Notwithstanding the arsenal of antibiotic drugs developed in last decades and, 
socioeconomic background of outbreaks or epidemic level of colibacilosis, tuberculosis, or 
cholera in Developing Countries, an underlying problem is challenging ahead: the eclosion 
of more virulent and resistant microbes. This is an unreliable phenomenon that stresses 
health care systems in countries and regions (von Baum & Reinhard Marre, 2005; Marcusson 
et al., 2009; Mediavilla et al., 2005; Wagenlehner & Naber, 2004).   
One of the ways by which microbes avoid antibiotic products is by biofilm formation, a 
usually lipospolisacaride based microorganism aggregates that confer protection, it is a 
selective advantage for persistence under hostile environmental conditions; biofilm also 
promotes host colonization. Few decades ago there was a common misunderstanding of the 
microcosm, since 99% microbes in nature live in communities as biofilms and not in 
planktonic forms as they were usually cultured and studied (Barreto & Rodríguez, 2009, 
2010). 
Microorganism biofilm are systems that behave as a whole, determining what, when, and 
how to interact with the environment (physical or biological). This is mediated by the so 
called quorum-sensing (QS), a cell-to-cell communication mechanism in which the 
expression of certain genes in response to the presence of small signal molecules is 
coordinated (Defoirdt et al., 2011, Dobrindt & Hacker, 2008).   
Urinary tract infections (UTIs) are a worldwide health problem, second only to infections of 
the respiratory tract. Sexual active women are the most susceptible population to UTI, but it 
is also frequent in elder people and catheterized patients. Escherichia coli is the prevalent 
etiological agent isolated in UTI (Johnson, 1997; 2003; Scholes et al., 2000; Svanborg & 
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Godaly, 1997; Zhang & Foxman, 2003). Chemotherapy is the main UTI conventional 
therapy, but antibioresistant strains are continuously emerging, for this reason, antibiotics 
therapy is sometimes inefficient, specially for  _lactamics, trimethoprim-sulfamethoxazole, 
and more recent drugs like fluoroquinolones (von Baum & Reinhard Marre, 2005; Drekonja 
& Johnson, 2008; Gupta et al.,1999; Hooton, 2003; Jadhav et al., 2011; Mediavilla et al., 2005; 
Storby, 2004; Wagenlehner & Naber, 2004). 
In this never ending cycle, there is a race to develop different kinds of vaccines and effective 
new generation drugs. But it seems that immunologicals or antibiotics are not an exclusive 
criterion to deal with bacteria, some other subtle ways can be even more promising. If 
microorganism advantage adaptations are interfered, host abilities to overcome infection 
and restore itself will be increased.   
This review deals with microbiological sciences related to the search of new antibacterial 
mechanisms, fimbriae as a virulence factor target, and the possibilities of using plant origin 
compounds as antiadhesive in bacterial attachment, particularly exposed by studies on 
uropathogenic Escherichia coli.  
2. Uropathogenic Escherichia coli and virulence factors 
Escherichia coli (Escherich, 1885 - Enterobacteriaceae) is a versatile bacteria that has become the 
most thoroughly studied organism in the planet (Barreto, 2007), it is a human and warm-
blooded animal enteric comensal but, as a result of genetic fluidity of pathogenicity 
encoding genes, it could have different pathogenic behaviours (Dobrindt, 2005; Ahmed et 
al., 2008; Schubert et al., 2009); therefore, E. coli can become in a virulent bacteria adapted to 
different niches. Beside gastroenteritis, it can cause urinary tract infection, abdominal sepsis, 
septicaemia, and meningitis.    
Eight virulence factors (VFs) armed pathovars have been described and classified as either 
diarrheagenic E. coli, enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli (EHEC), 
enterotoxigenic E. coli (ETEC), enteroinvasive E. coli (EIEC) including Shigella, 
enteroaggregative E. coli (EAEC), and diffusely adherent E. coli (DAEC); or extraintestinal E. 
coli (ExPEC), uropathogenic E. coli (UPEC); and neonatal meningitis E. coli (NMEC) 
(Sasakawa & Hacker, 2006; Croxen & Finlay, 2010).   
Uropathogenic E. coli is a facultative enteric bacterium, but if carrying some VFs, it can reach 
the lower urinary tract and cause cystitis or, travel further into the kidneys and cause 
pyelonephritis (Croxen & Finlay, 2010; Dobrindt & Hacker, 2008; Zhang & Foxman, 2003). 
UTI it is much more common in young women than men and female anatomy is 
determinant. It is estimated that 11 percent of women in U.S.A. are diagnosed for UTI every 
year, about half of all women have a UTI by their late twenties, 20-30 percent will have two 
or more infections, and 5 percent will suffer from recurrent UTI (Foxman et al., 2000; Zhang 
& Foxman, 2003).  
It is a fact that comensal enteric bacteria must carry a subset of VFs, required in a hostile 
environment like the urinary tract, to be an ExPEC, and explore niches outside the 
gastrointestinal tract. Virulence factors provide mechanism by which bacteria survive at 
least for a period of time needed for each step of infection. Tropism in UPEC is remarkable; 
once it reaches the uroepithelium, it attaches to its surfaces impeding urinary mechanical 
clearance and starting colonization; then, it travels to the bladder and kidneys; haeminic 
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iron could be a gold medal in nephrones. However, UPEC needs a toolbox of VFs like: 
adhesins, alpha-haemolysin, cytotoxic necrotizing factor, and iron acquisition systems, to 
cause cystitis and pyelonephritis, which are associated with a number of symptoms such as: 
inflammation, haematuria, urohaemolitic syndrome, and renal scars; while subvert host 
unspecific immunity, provoke epithelial exfoliation and invade deeper cells (Gal-Mor & 
Finlay, 2006; Johnson, 1997, 2003; Kaper et al., 2004; Wiles et al., 2008).  
Genetic expressions of VFs are coordinated by QS as a way to be effective in colonization 
and surviving at least of a reduct of bacterial cell in each infection step. In a recent review, 
Wu et al. (2008) classified VFs as follows:  
 Membrane proteins, which play roles in adhesion, colonization, and invasions; promote 
adherence to host cell surfaces, are also responsible for resistance to antibiotics, and 
intercellular communication 
 Polysaccharide capsules that surround the bacterial cell and have antiphagocytic 
properties 
 Secretory proteins, such as toxin which can modify the host cell environment and are 
responsible for some host cell–bacteria interactions 
 Cell wall and outer membrane components, such as lipopolysaccharide (LPS or 
endotoxin) and lipoteichoic acids 
 Other virulence factors, such as biofilm forming proteins and siderophores  
Virulence factors play a key role in adaptation and evolution. According to Jain et al. (2010), 
microbes either communal or individual ones provoke chronic or persistent infections, 
which are largely associated with populations of microbes, and have individual bacterial 
virulence traits associated with acute infections. VFs are encoded in large continuous blocks 
of virulence in genome, named pathogenicity associated islands (PAIs), and their expression 
can be regulated by the host and by environmental signals (Bergsten et al., 2005; Gal-Mor & 
Finlay, 2006; Johnson, 1997). Horizontal DNA transfer is mediated by plasmids, phages, and 
PAIs; this is one of the processes that generate bacterial and host genome evolution (Ahmed 
et al., 2008; Beauregard-Racine et al., 2011; Schubert et al., 2009; Tettelin et al., 2008; 
Zaneveld et al., 2008).   
In E. coli pathotypes, several VFs are associated and could be expressed at the same time or 
not. In the last two decades, VFs research in molecular biology has advanced enough to 
explain different mechanisms of UPEC pathogenesis, and modern “omics” are focussed in 
relation to PAIs and UTI epidemiology; thus, aetiology of UTI is better understood, different 
purposes to disrupt VFs are supported, therapeutic guidelines can be much more successful, 
and new approaches on antimicrobials research are rendered (Ahmed et al., 2008; Dobrindt, 
2005; Henderson et al., 2009; Johnson, 1997; Johnson & Russo, 2006; Westerlund-Wikström & 
Korhonen 2005; Zhang & Foxman, 2003). A lethal battery of VFs is responsible for the 
human food borne virulent E. coli 0157:H7 and the European recent lethal E. coli O104:H4, 
both strains produce hemolytic uremic syndrome.  
2.1 Uropathogenic E. coli and fimbriae 
Pili or fimbriae are hair-like polymeric (assembled from multiple subunits) proteinaceous 
appendages expressed on the outer surface of bacteria that enable pathogens to recognize 
host receptors, anchor, and begin infection; adhesion is produced by a bacterial adhesin 
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located at the tip of a pilus structure (Dodson et al., 2001; Johnson, 1997, 2003; Niemann et 
al., 2004). Fimbriae are determinant in early steps of colonization of most E coli pathovars. In 
UPEC are significant, they avoid lavage by the host, attaching to the urinary tract mucosa 
and triggering signals to start the disease process. This VF is associated to invasion, biofilm 
formation, cell motility, and transport of proteins and DNA across membranes (Gal- Mor & 
Finlay, 2006; Johnson, 2003; Kaper et al., 2004; Wiles et al., 2008).   
If fimbriae-receptor interaction is not well established, UTI symptoms never occur; when 
bacterial persist in this condition the patient will have an asymptomatic bacteriuria (ABU). 
Adhesins have been termed as the most important determinant of pathogenicity (Le 
Bouguénec, 2005; Croxen & Finlay, 2010; Mulvey, 2002; Niemann et al., 2004;  Sauer et al., 
2000). The process of a UTI is viewed by Schilling et al. (2001) as a number of measures and 
counter-measures taken by the host and UPEC. The disease is triggered by fimbriae, 
inducing the host and bacterial cells signal pathways that involve different mutual 
responses. In the ‘‘two-step’’ model of UTI pathogenesis described by Bergsten et al. (2005), 
the first step is the activation of the innate response, and the second one is the effector phase 
involved in bacterial clearance, which depends on neutrophils and their ability to remove 
lingering inflammatory cells and bacteria. Electron microscopy shows hat this 
immunological response could be advantageous to bacteria, because it allow them to 
internalized and survive at the underlying bladder epithelium and creating a reservoir 
protected from immune surveillance and antibiotics. They remain in a quiescent state for 
several weeks before reemerging and provoking a recurrent acute infection (Caper et al., 
2004; Lane & Mobley, 2007; Mulley et al., 2001; Mulley, 2002). 
Uropathogenic E. coli type 1 fimbriae and type P fimbriae, are molecularly and 
epidemiologically well characterized. Both types of fimbriae are assembled in cell bacteria 
by a highly conserved periplasmatic chaperone and outer membrane usher proteins (Le 
Bouguénec, 2005; Waksman and Hultgren, 2009). Type 1 fimbriae are so far, the most 
common adhesin in non complicated low UTI (cystitis); while P fimbriae, encoded by E. coli 
pap (pyelonephritis-associated pilus) operon, adhere to kidney uroepithelium (Croxen and 
Finlay, 2010; Verger et al., 2007). Fimbriae can be classified according to their receptor-
binding specific traits. Type 1 fimbriae mediate mannose-sensitive haemagglutination 
(MSHA), but P fimbriae are cause of mannose-resistant haemagglutination (MRHA) 
(Abraham et al. 1998; Johnson, 2003; Westerlund-Wikström and Korhonen, 2005).   
Haemagglutination is an E. coli visual test to detect types 1 and P bacterial fimbriae, since 
some red blood cells (RBC) have carbohydrate residue receptors similar to adhesin 
uroepithelial receptors. When the adhesin of a bacterial cell suspension contacts the receptor 
of a RBC suspension, a surface reaction occurs and the RBC aggregate like macroscopic 
glomerules. Uroepithelial cells and oral cells can lead to an agglutination reaction too. 
Designation of P fimbriae is for the ability of these E. coli strains to agglutinate P blood 
antigens erythrocytes (Johnson, 1991).    
Type 1 fimbriae consist in a 7 nm thick helical rod with a tip structure containing the 
adhesin FimH and two adaptor proteins, FimF and FimG. About 70 % of isolated UPEC 
encoded a variant of FimF adhesin that binds to monomannose residues. In addition to 
trimannose receptors, this affinity to monomannose receptors leads to tropism within 
uroepithelial cells (Johnson, 2003; Mulvey, 2002; Niemann et al., 2004; Verger et al., 2007). P 
fimbria is a 6.8 nm rod composed of repeating PapA subunits arranged in a right- handed 
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helical cylinder, with a distally located adhesin PapG on its tip. Receptors of P pili are 
globoseries of membrane glycolipids with a disaccharide galabiose (Gal-α (1-4)-Gal). There 
are three PapG alleles (I-III) which bind to different isoreceptors that differ in carbohydrate 
residues to the common Gal-α (1-4)-Gal core. PapG II binds mainly to globotetrasyl 
ceramide (GbO4) and it is associated with pyelonephritis symptoms like inflammation and 
uroepithelial exfoliation (Dodson et al., 2001; Johnson, 2003; Mulvey, 2002; Niemann et al., 
2004; Westerlund-Wikström & Korhonen, 2005; Wullt, 2003;). It was demonstrated that class 
II adhesin is a prerequisite for acute pyelonephritis in primates; besides, in induced mixed 
infection with P fimbriated E. coli and not fimbriated strains it gives a competitive 
advantage to colonize bladder (Winberg et al., 1995).  
The role of fimbriae as virulent factor in UTI pathogenesis has been thoroughly studied in 
the last thirty years, also confirming the special pathogenesis theory by means of modern 
methods (Beached, 1981; Johnson, 2001, 2003; Kaper et al., 2004; Verger et al., 2007; Wiles et 
al., 2008; Zhang & Foxman, 2003). See most of the review articles cited in this subchapter for 
details and graphics of VFs effects and UTI steps. 
3. Experiences against fimbrial adhesion 
Interference of VFs is an attractive approach to manage diseases due to bacterial infection. In 
the case of UPEC, fimbriae are an important target to prematurely neutralize them, before 
they spread within urinary tract, and if is not timely flushed out become in an asymptomatic 
bacteriruria. Beside UTI overcome, if this purpose is clinically effective, it is expected in 
these conditions that possibility of generating antibioresistance will be remote.    
Fimbriae have been studied from different perspectives. Regarding enteropathogenic and 
uropathogenic E. coli, Barreto et al. (2001a) reviewed the following experimental attempts:   
a. sublethal antibiotic concentrations: fimbrial adhesive ability of E. coli to attach to 
uroepithelium, enterocytes, and some erythrocytes could be decreased by a previous 
exposition to sublethal antibiotic concentrations of amphicillin, gentamycin, 
sulfonamides, trimethropim, and tetracycline, however, nalidixic acid can increase 
adhesion (Barreto et al., 1994; Hales & Aymes, 1985; Johnson, 1991; Padilla et al., 1991; 
Stenquist et al., 1987; Vosbeck et al., 1982). Sublethal amounts of gentamycin, 
chloramphenicol and kanamycin tested in E. coli G7 inhibit adhesiveness in this strain at 
95%, 85%, 80% y 75%, respectively (Barreto et al., 1994). It was found that, in general, 
those antibiotics that inhibit protein synthesis also inhibit fimbrial expression at 
sublethal concentrations of either P fimbriae, or K88 and K99 fimbriae (Padilla et al., 
1991; Barreto et al., 1994), without culture media influence (Barreto et al., 1995a, 1995b). 
But this is not the best option in therapy as it has the limitation of antibioresistance 
emergence (Barreto et al., 2000). 
b. immunological methods (antifimbrial vaccines, monoclonal antibodies): 
Search for a vaccine that blocks E. coli fimbriae has been performed since the 1980´ and 
many results have been obtained, mainly in veterinary medicine. Several methods have 
been applied to obtain this products, attenuated strains, semipure antigenic extracts, 
and recombinant technology (Barreto et al., 2001a; Ofek et al., 2003; Campal et al. 2007, 
2008). Fimbrial subunits vaccines are more efficient than conventional ones, since other 
non-protective cell components, or endotoxins that induce shock, vascular permeability, 
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and abortion in swine are not present (Kaper & Levine, 1988; Levine et al., 1993; Wong 
et al., 1995). In Cuba, the administration of VACOLI® vaccine to swine protect piglet by 
suckling in a 93 %, and in 98 % post-weaning (Wong et al., 1995).  
A vaccine that induces an antibody response against FimH was tested in humans proving its 
effectiveness against an UPEC strain in mouse cystitis model (Langermann et al., 1997; 
Langermann & Ballou, 2003). A high level of protection against P fimbriae has been 
developed too in a primate model (Soderhall et al., 1997). Molecular microbiology of 
bacterial pathogenesis and new technologies show favorable expectations concerning 
discoveries of new vaccines against bacterial infectious diseases (Moingeon et al., 2003; 
Sasakawa & Hacker, 2006; Westerlund-Wikström & Korhonen, 2005). The wide fimbriae 
diversity encoded by enteric E. coli, and the selective pressure exerted by vaccination 
usually make bacteria population change toward fimbrial fenotypes not covered by the 
vaccine. On the other hand, adhesin diversity of enteropathogenic E coli is higher in human 
beings than in animals; antigenic diversity is the principal disadvantage for an UPEC P 
fimbriae vaccine (Barreto, 2007; Barreto & Campal, 2001; Barreto et al., 2001b). 
c. medicinal plant extracts: it is exposing in next epigraph. 
Some of these items were coincident with the strategies for UTI management mentioned by 
Reid (1999): prophylaxis by antibiotics, including natural peptides; vaccines, probiotics and 
others like avoiding spermicide and keeping a proper hygiene. In a review about anti-
adhesion therapy for different bacterial germs, Ofek et al. (2003), referred to receptor 
analogs and adhesin analogs as anti-adhesive agents, dietary inhibitors of adhesion, 
adhesin-based vaccines, and host-derived anti-adhesins in innate immunity.  
4. Medicinal plants extracts and virulence factors 
In the last years, attention to medicinal plant research related to VFs inhibition as a target 
activity is increasing; several bioassays to evaluate VFs have been develop for several 
microorganisms, mainly bacteria and yeast. This is a valuable source of compounds to 
investigate new anti-virulence factors mechanisms of pathogenic microbes.   
Different medicinal plant metabolites have antimicrobial activity (Cowan, 1999; Mahady, 
2005). In traditional medicine systems of diverse cultures and regions, plants to treat urinary 
tract diseases are well known. Usually the same species are used for different purposes or 
medical conditions related to urinary system, i.e. as diuretic (most common), antilithic, and 
agents for cystitis or pyelonephritis treatment. However common people call all of them as 
“kidney diseases” or “urinary complaints”. 
Researches focused on adhesin-receptor medicinal plants interference are recent, since few 
studies have reported this action in plants, except those related in vitro, in vivo, and clinical 
trial of UPEC antiadhesion effects of cranberry fruit (Vaccinium macrocarpon Ait., Ericaceae). 
This is the only one commercial herbal product or food claimed as an antiadherent for UTI 
treatment. Besides, cranberry was among the top ten marketed herbal products in U.S. in the 
1990´ (Siciliano, 1998).  
In Cuba, first reports about plant extracts against fimbrial adhesion are those of Eucabev, an 
antidiarrheic drug for veterinary use, manufactured from Eucaliptus spp. (Myrtaceae) bark. 
www.intechopen.com
 
Antiadhesive Effect of Plant Compounds in Bacteria 
 
49 
After using a decoction of Eucaliptus spp. bark to treat diarrheic syndrome in different 
animal species (Velázquez et al., 1991), and confirming no bactericide or bacteriostatic effect 
on ETEC at several concentrations (Barreto et al., 1993a), an antiadhesive  mechanism of this 
plant was explored as antidiarrheic. Enteropathogenic E. coli strains G7 (08 K87, K88ab) and 
B44 (09 K30, K99) were tested as fimbrial antiadhesives by MSHA assay (Blanco & Blanco, 
1993) or monoclonal antibodies assays. After exposure of each strain in media cultures with 
decoction, infusion, and water extract of Eucaliptus saligna and E. citriodora, fimbriae 
inhibition was found significant, 83,3% and 100%, respectively (Barreto et al., 1993b, 1993c; 
1995a, 1995b; Barreto & Campal, 2001). 
Similar experiments were carried out to screen P fimbriae-receptor interference in UPEC 
strains of medicinal plants traditionally used for urinary diseases. Wild E coli P+ strains 
cultured or not with Lepidium virginicum (Apiaceae) and Achyranthes aspera (Amaranthaceae) 
extracts were tested by MRHA assay (Guerra et al., 1995; Prieto et al., 1995). Then, plant 
antiadhesin activity was determined by MRHA and anti-PapA monoclonal antiserum assays 
in E. coli ATCC 25922 to screen extracts of A. aspera, L. virginicum, Ageratum conyzoides 
(Asteraceae), Zingiber officinale (Zingiberaceae), Curcuma longa (Zingiberaceae) and Costus speciosus 
(Costaceae). Antiadhesive effect was detected in all plant species except C. longa extracts 
(Barreto et al., 2001). Besides, based on a previous study on K99 adhesin, effect of plant extracts 
on erythrocytes receptors was evaluated (Barreto et al., 1993b), finding activity in all plant 
species. Results of antiadhesin effect and Gal-Gal receptors are summarized in Table 1. 
 
Plant Extracts Effect on fimbriae Effect on receptors 
A. aspera ethanol 90% - - 
ethanol 20% - - 
decoction - + 
L. virginicum ethanol 90% + + 
ethanol 20% - - 
decoction - - 
A. conyzoides ethanol 90% - - 
ethanol 20% - - 
decoction - - 
Z. officinale ethanol 90% - - 
ethanol 20% - + 
decoction - - 
C. longa ethanol 90% + + 
ethanol 20% + + 
decoction + - 
C. speciosus ethanol 90% + + 
ethanol 20% - + 
decoction + - 
Table 1. Effect of plant extracts on fimbrial expression and fimbrial receptors, from Barreto 
et al., (2001). (+ = positive adhesion - unaltered fimbriae or receptors; - = no adhesion -no 
expression of fimbriae or altered receptors). 
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Source Microorganism Effects on Virulence 
Factor 
Reference 
Vaccinium macrocarpon (Ericaceae) See epigraph below 
Berberis aristata (Berberidaceae) 
berberine sulfate 
UPEC inhibit adhesion Sun et al., 1988a 
B. aristata berberine sulfate Streptococcus 
pyogenes 
inhibit adhesion to 
epithelial cells, 
fibronectin, and 
hexadecane 
Sun et al., 1988b 
Arctostophylos uva-ursi (Ericaceae) 
Vaccinium vitis-idaea 
E. coli enhance aggregation  Türi et al., 1999 
Matricaria recutita (Asteraceae) 
M. matricarioides  
block aggregation 
Psidium guajava (Myrtaceae) 
galactose-specific lectin 
E. coli 0157:H7 inhibit adhesion to red 
cells 
Coutiño et al., 
2001 
Azadirachta indica (Meliaceae ) Streptococcus 
sanguis 
inhibit adhesion Ofek et al., 2003 
Camelia sinensis (Theacae) (green tea) 
(-) epicatechin gallate, (-) 
gallocatechin gallate 
P. gingivalis
(oolong tea) polyphenol S. mutans, 
S. sobranus 
Galanthus nivalis (Amaryllidaceae) 
mannose-sensitive lectin 
E. coli
Gloipeltis furcata and Gigartina teldi 
(seaweeds) sulfated polysaccharides 
S. sobrinus 
Humulus lupulus (Urticaceae) bract 
polyphenols 
S. mutans
Melaphis chinensis gallotannin S. sanguis
Persea americana (Lauraceae) tannins S. mutans
Andrographis paniculata  (Acanthaceae) S. mutans inhibit adhesion Limsong et al., 
2004 Senna alata (Cassia alata) 
(Caesalpinaeae) 
C. sinensis  
Harrisonia perforata  (Simaroubaceae) 
Punica granatum (Punicaceae) Staphylococcus 
aureus 
Staphylococcal 
enterotoxin A 
Braga et al., 2005   
Streblus asper (Moraceae) leaf Candida albicans inhibit adhesion to 
denture acrylic 
Taweechaisupa-
pong et al., 2006 
Resveratrol (found in grapes seeds- 
Vitis vinifera) (Vitaceae) 
Proteus mirabilis Swarming,  flagella, 
haemolysin and urease 
Wang et al. 2006 
Conocarpus erectus (Combretaceae) Chromobacterium 
violaceum and  
Agrobacterium 
tumefaciens 
quorum sensing- 
disrupting (QS-D) 
Adonizio et al., 
2006 Chamaecyce hypericifolia 
(Euphorbiaceae) 
Callistemon viminalis (Myrtaceae) 
Bucida burceras (Combretaceae), 
Tetrazygia bicolor (Melastomataceae) 
Quercus virginiana (Fagaceae). 
V. macrocarpon  C. violaceum QS-D Vattem et al., 2007 
V. angustifolium  
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Rubus idaeus (Ericaceae)
R. eubatus  
Fragaria sp. (Rosaceae)
Vitis sp. 
Origanum vulgare (Lamiaceae)
Rosemarinus officinalis (Lamiaceae)
Ocimum basilicum (Lamiaceae)
Thymus sp. (Lamiaceae) 
Brassica oleracea (Brassicaceae) 
Curcuma longa (Zingiberaceae) 
Zingiber officinale (Zingiberaceae) 
Galla chinensis  E. coli (ETEC) heat-labile enterotoxin Chen et al., 2006 
Z. officinale   E. coli (ETEC) heat-labile enterotoxin Chen et al., 2007a 
Chaenomeles speciosa fruit (Rosaceae) E. coli (ETEC) heat-labile enterotoxin Chen et al., 2007b 
Pelargonium sidoides (Geraniaceae) Helicobacter pylori inhibit adhesion to 
intact human stomach 
tissue
Wittschier et al., 
2007 
P. sidoides (Geraniaceae) Streptococcus
pyogenes 
HEp-2 cells and buccal 
epithelial cells  
Conrad et al., 
2007 
V. angustifolium or V. corymbosum  
V. myrtillus  
V. ovalifolium, V. ovatum, V. 
parvifolium  
H. pylori and
Streptococcus spp. 
adhesion Yarnell & 
Abascal, 2008 
C. sinensis  S. mutans
Galla chinensis1 methyl gallate (MG) 
and gallic acid (GA) 
S. mutans antibiofilm Kang et al., 2008 
Holarrhena antidysenterica
(Apocynaceae) 
EPEC inhibit adhesion to 
enteric epithelial cells  
Kavitha & 
Niranjali 2009 
Glycyrrhiza glabra (Fabaceae) Porphyromonas 
gingivalis 
adhesion Wittschier et al., 
2009 
G. glabra glycyrrhizin E. coli (ETEC) Heat-labile enterotoxin Chen et al., 2009 
Ibicella lutea (Martyniaceae) aereal part Proteus mirabilis swarming 
differentiation, 
hemagglutination and 
biofilm formation 
Sosa, & Zunino et 
al., 2009 
Dodonaea viscosa var. angustifolia
(Sapindaceae) 
C. albicans adherence to oral 
epithelial cells 
Patel et al., 2009 
Aegle marmelos (Rutaceae) unripe fruit 
decoction 
E. coli (EPEC),  
E. coli (EIEC) and 
Shigella flexneri 
Adhesion to HEp-2 cell 
line, decrease 
production of heat 
labile toxin and its 
binding to ganglioside 
monosialic acid 
Brijesh et al., 2009 
P. guajava decoction E. coli (EPEC),  
E. coli (EIEC) and 
S. flexneri 
idem. Birdi et al., 2010 
P. sidoides root extract specific 
proanthocyanidins 
S. pyogenes anti-adhesion Janecki et al., 2011 
                                                 
1 Gall caused by aphids on Rhus spp. (Anacardiaceae) 
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Piper bredemeyeri (Piperacae) C. violaceum QS-D Olivero et al., 
2011 P. brachypodom   
P. bogotence  
Terminalia catappa (Combretaceae) 
Tannin-rich fraction 
C. violaceum and 
Pseudomonas 
aeruginosa 
QS-D  
antibiofilm and LasA 
staphylolytic activity 
Taganna et al., 
2011  
Delisea pulchra  (red marine alga) 
Halogenated furanones 
bacteria QS-D  Defoirdt et al., 
2011 
Halobacillus salinus isolated from sea 
grass, phenetylamide metabolites 
bacteria including 
Vibryo harveyi 
Compounds bacteria isolated from a 
marine alga Colpomenia sinuosa 
bacteria 
Chamaecrista desvauxii (Fabaceae) 
Fruits 
Staphylococcus 
epidermidis  
antibiofilm  Trentin et al., 2011 
Commiphora leptophloeos (Burseraceae)  
Stem bark 
Dioclea grandiflora (Fabaceae) Fruits 
Eugenia brejoensis (Myrtaceae) Leaves 
Libidibia ferrea var ferrea
(Caesalpinaeae) Fruits 
Melocactus zehntneri (Cactaceae) Roots, 
Cephalium 
Myracrodruoun urundeuva
(Anacardiaceae) Leaves, Branches, 
Stem bark 
Myroxylon peruiferum (Fabaceae)  
Leaves 
Parkinsonia aculeata  (Caesalpinaeae) 
Leaves 
Piptadenia viridiflora (Mimosoideae) 
Branches, Fruits 
Pityrocarpa moniliformis 
(Mimosoideae) Leaves 
Polygala boliviensis (Polygalaceae) 
Leaves, Branches 
P. violacea Leaves, Roots 
Senna macranthera (Caesalpinaeae) 
Fruits 
S. splendida Branches  
Sida galheirensis (Caesalpinaeae) 
Leaves, Branches 
Euphorbia trigona (Euphorbiaceae) latex 
extracts 
P. mirabilis and 
P.aeruginosa  
swarming, antibiofilm 
rhamnolipid 
production inhibition 
of urease 
Nashikkar et al., 
2011 
Lactuca indica (Asteraceae)  E. coli inhibit effect on focus 
adhesin kinasa 
phosphorylation 
Lüthjea  et al., 
2011 
Table 2. Effect of natural products on microorganism virulence factor.  
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There is an increasing evidence that plant metabolites can inhibit different VFs expressions 
allowing host defense to overcome an infection; for instance, fimbrial adhesin interference in 
UTI, that is fundamental to avoid bacterial colonization, invasion, and then disease first 
symptoms. Results show this is a plausible mechanism by which maybe underestimated 
non-bacteriostatic/bactericides medicinal plants, traditionally used in treating “urinary 
complaints” are worthy. 
Some studies of medicinal plants, food plants and seaweeds against different VFs on several 
Gram positive bacteria, Gram negative bacteria, and against Candida albicans are compiled in 
Table 2. Referring more than 60 plant species from diverse families, but there really are few 
species considering the potential of the world flora. Of particular interest is the evidence of 
activity of edible plants or seasoning plants like: Camellia sinensis (Theacae), Psidium guajava 
(Myrtaceae), Vitas vinifera (Vitaceae) and Zingiber officinale (Zingiberaceae), since daily ingestion 
as food of such plants could prevent infections. Ginger and Curcuma with antifimbrial UPEC 
activity (Table 1) are reported too as anti quorum sensing-disrupting. Most of summarized 
plants have traditional renown in microbial gastrointestinal disorders or urinary complaints 
treatment (Roig, 1974).  
E. coli references are related to antiadhesion activity, or inhibition of toxins of enteric 
pathotypes; and in an early reference of Sun et al. (1988a), it is described the antiadhesive 
effects of berberine alkaloids inhibiting the expression of fimbrial subunits on UPEC. There 
are also studies on antiadhesion properties of certain plant extracts against oral and dental 
plaque forming bacteria.    
In some studies, modern technology search for non-conventional antimicrobials is based on 
folk medicine (Birdi et al., 2010; Brijesh et al., 2009; Chen et al., 2007a, 2007b, 2009; Coutiño et 
al., 2001; Kavitha & Niranjali 2009;). In recent years, the increase in number of articles 
including new trends in VFs research, like biofilm inhibition or quorum sensing-disrupting 
is noticeable. Screening is reported for quorum sensing-disrupting in dietary plant (food or 
seasoning plant) (Vattem et al., 2007), in which all species were active. Taking into account 
ethnobotanic criteria, a quorum sensing-disrupting and antibiofilm effects of plants from 
Florida, USA, and Caatinga plants from Brazil, respectively, were screened (Adonizio et al., 
2006; Trentin et al., 2011).  
Several VFs can be neutralized by plant compounds. A broad field of research on this 
subject is ahead; science advances in phytochemistry, molecular microbiology, in silico 
designs, and “omics” providing new features that will end in VFs based new therapy 
strategies. Another point is that, like in other biological activities, ethnomedical knowledge-
based criteria can afford success in the search for antivirulence factor novel drugs or herbal 
medicine (Abreu & Cuéllar, 2008). 
4.1 Cranberry (Vaccinium macrocarpon) antiadhesive therapy leader 
Cranberry is a fruit currently use widely as food and as medicine mainly for women in 
prophylaxis of ITU because of its antibacterial properties. Herein are present a bulk of 
information that allows stating that cranberry can be consider as a leader in the bacterial 
antiadhesive therapy.  
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4.2 Botany 
Taxonomy: Ericaceae family, Vaccinioideae Subfamily, Vaccinieae Tribe; the genus comprises 
450 species (Berazaín, 1992). Among the most common species  used as medicine and food 
are V. mirtillus (blueberry), and V. corymbosum (highbush), V. ashei (rabbiteye) and V. 
angustifolium (lowbush). Description: V. macrocarpon is an evergreen trailing shrub, 
rhizomatous habits when young; pink, simple, axilar flowers. Ovary has four locules. Wind 
or insects are needed for pollination. Fruit is a shining red epigynous berry, ripening occurs 
60-120 days after pollination. Distribution: east bogs in North America, from Newfoundland 
to Manitoba, south of Virginia, Ohio and north of Illinois. 
4.3 Traditional use 
Native people from North America cranberry use fruit as food in meat dishes and as 
medicine for erysipelas, tonsilitis, scarlatina sore throat, ulcers, pleuresy (leaves) (Moerman 
(2004); cancer and scurvy (Duke, 2007), and to treat cystitis and prevent UTI (Farnsworth, 
2003). 
4.4 Phytochemistry 
V. macrocarpon is among the most phytochemically studied Vaccinium species (Abreu et al., 
2008). Cranberry fruit mainly contains organic acids such as: citric, chlorogenic, malic, 
quinic and shiquimic acids (Duke, 1992; Jensen 2002); and polyphenols like flavonoids, and 
anthocyanic pigment glycosides of cyanidin and paeonidin (Abreu et al., 2008; Duke 1992). 
Polyphenolic compounds have been the most researched in Vaccinium spp. because of its 
antioxidant and anti-UTI activity, mainly in V. macrocarpon and V. mirtillus fruits.  
Trimeric type A proanthocyanidines characterized in cranberry by Foo et al. (2000a), is of 
particular interest, since authors demonstrated it is the active compound in UPEC P fimbriae 
interference. 
4.5 In vitro and in vivo antimicrobial activity 
Almost all biological effects of cranberry fruit so far evaluated are antimicrobial activity. 
There are references of antivirus activity (Konowalchuk & Speirs, 1978), antifungal activity 
(Cipollini & Stiles, 1992; Marwan & Nagel, 1986) and antibacterial activity (Lee et al., 2000; 
Leitão et al. 2005; Marwan & Nagel, 1986). The last author reports no activity of cranberry 
juice (pH- 3, 5 and 6, 9) and cranberry proanthocyanidin-rich fractions against E. coli and 
other bacteria. Thus, cranberry use in UTI prevention or treatment is not due to 
bacteriostatic/bactericide activity; however, there is a great number of in vitro and in vivo 
research related to the antiadhesive effect of cranberry on UPEC P+. Besides, there are 
reports of cranberry as a fimbrial antiadhesive in other bacteria (Moerman et al., 2003).   
At the beginning of 20th century, antimicrobial cranberry studies were based on the 
possibility of acidification of urine or by excretion of hypoxic acid, a potent bacteriostatic 
associated to the fruit ingestion (Blatherwick, 1923; Moen, 1962); but other results 
questioned this mechanism (Fellers, 1933; Nickey, 1975). It is in the 1980’ that research on 
bacterial adhesion began to be considered as a mechanism of action of cranberry in UTI 
(Schmidt & Sabot, 1989; Sabot, 1984; Safire et al., 1989); since then, dozen of articles have 
been reporting in vitro, ex vivo, and in vivo experiences of its antiadhesion activity. Among 
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models used were HARM and HASR in guinea pigs and human erythrocytes; uroepithelial 
cells, bladder cultured cell lines and laboratory animal models (Nowak & Schmitt, 2008). 
Using micro plate technology and turbidity assessment for testing the adherence of 
Escherichia coli P+ to human uroepithelial cell line T24, Turner et al. (2005), developed a high- 
throughput assay to study V. macrocarpon extracts. A bioassay like this could also be use in 
the screening of extracts of plants used traditionally in urinary tract system diseases.  
Certainty on cranberry antifimbrial effect was achieved by Ahuja et al. (1998) by means of 
electronic microscopy, no fimbrial expression or loose of them, and change in E. coli 
morphology were clear. More recently, isolated cranberry proanthocyanidins (PACs) at 60 
µm/ml were tested on UPEC P+ resulting in a potent antiadhesive activity (Foo et al., 2000a, 
2000b, Howel et al., 2005). 
Ex vivo studies on exposed UPEC strains in urine from healthy volunteers under different 
cranberry administration schedules, and several researches on humans have validated 
cranberry for UTI prevention. Prospective clinical trial in young women with recurrent UTI 
has demonstrated a protective effect. In a metaanalysis of human clinical trials, Jepson & 
Craig (2008) conclude that:  
“There is some evidence that cranberry juice may decrease the number of symptomatic UTIs 
over a 12 month period, particularly for women with recurrent UTIs. Its effectiveness for 
other groups is less certain. (...) The evidence is inconclusive as to whether it is effective in 
older people (both men and women), and current evidence suggest that it is not effective in 
people with a neuropathic bladder. (...) Further properly designed studies with relevant 
outcomes are needed.” 
4.6 Proanthocyanidins 
Proanthocyanidins (condensed tannins) are oligomeric and polymeric end products of the 
flavonoid biosynthetic pathway. They are present in the fruits, bark, leaves and seeds of 
many plants, where they provide protection against predation. They are charactehrized by 
their flavor and astringency in beverages like wine, tea, and fruit juices; and they have been 
used as leather tanning agents for a long time. An important property of this kind of tannins 
is their ability to bind proteins; hence they can inhibit enzymes and reduce protein 
availability in animal nutrition (Dixon et al., 2005; Miranda & Cuéllar, 2001). Like other 
plant polyphenol compounds, in recent years PACs have been biologically studied, mainly 
for their antioxidand activity (King et al., 2007). In general, their bioavailability is poor, since 
PACs high molecular weight difficult absorption, but this could be beneficial for gut health 
due to their effects on lipid oxidation, inflammation, immunity, and pathogenic bacterial 
adhesion (Reed & Howell, 2008).  
Unusual A-type proanthocyanidins (B-type linkage is more common in plant kingdom), 
consisting primarily of epicatechin tetramers and pentamers (Fig. 1), with at least one A-
type linkage has been elucidated in UPEC antiadhesive active fractions of cranberry. It is 
structurally characterized by a linkage between C2 of the upper unit (C ring), and the 
oxygen at C7 of the starter unit (A-ring), in addition to the linkage between C4 of the upper 
unit and positions 6 or 8 of the lower unit (Dixon et al., 2005; Foo et al., 2000b;. Howell et al., 
2005). A-type linkage is a structural prerequisite for antiadhesion effects, since Howell et al., 
(2008) compared cranberry PACs with other B-type proanthocyanidins from commercial 
foods and not found in vitro or ex vivo activity.  
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Cranberry PACs decreases bacterial adhesion forces in UPEC (Pinzón-Arango et al, 2009) 
and influences Streptococcus mutans biofilms on saliva-coated apatitic surface and on dental 
caries development in vivo (Koo et al, 2010). Besides, cranberry PACs perform a cytotoxic 
activity in different cell lines (Singh et al., 2009). 
 
Fig. 1. Cranberry A-type proanthocyanidin.  
5. Possible mechanism of plant antiadhesion effects 
Chemical signal interactions between host and pathological microorganisms, or innocuous 
microorganisms have been recently understood, and seem to be very common in nature; in 
such magnitude, that plant origin product by host consumed could compete with microbes 
for specific receptors. These interactions are mediate by a complex dynamics of physico-
chemical and biological parameters, in which time can also be a prominent variable. 
Quorum sensing coordinated the infection steps recognizing each critical moment of the 
process by biofilm bacterial density.  
Mechanism of fimbrial adhesin inhibition can be related to different effects of plant 
metabolites such as: delection of genes encoding fimbrial subunits, enzymes or proteins 
associated to its transportation and allocation at the cell surface and cell receptor analogues 
that binds to adhesin subunits or nearby, impeding their interaction with receptors.  
Antifimbrial activity at genetic level is similar to some antibiotics mechanism proposed at 
sublethal concentrations (Barreto et al., 1994; Padilla et al., 1991); besides V. macrocarpon, this 
mechanism had been proposed for berberine alkaloid (Sum et al., 1988). 
Results on plant extracts blockade of adhesin-receptor interaction in RBC, suggest it can be 
mediated by glycoprotein (like lectins) with pectidic sequences similar to Pap G or Pap G-
Pap F, or by compounds that subvert spatial configuration of Gal-Gal receptors. In both 
cases, structural analogues of adhesin-receptor interaction could also be interfered due to 
esteric constraints.  
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Thermodynamic approach of fimbriae interaction is another point of view, in which Liu et 
al. (2008), calculate the Gibbs free energy of adhesion changes by interfacial tensions on 
human kidney uroepithelial cells and fimbriated or not fimbriated E. coli strains treated 
three hours with cranberry juice extracts.  
Interference of plant compounds in adhesin-receptor interaction should not promote 
microorganism antibioresistance, since at sublethal concentrations selection pressure is not 
established. Therefore, as effect is only exerted over pathogen VFs, it is not expected 
deleterious side effects on comensal microbiota as in chemotherapy usually occurs 
(candidiasis, colon disbacteriosis).  
Synergy it is known among plant metabolites, in this case for instance, some plant species 
reported in table 1 and table 2, besides antiadhesion effects, have activity on further VFs, 
thus, the sum of those effects help to avoid or suppress infection. In UPEC, is traditionally 
reported diuretic effect in those plants (Roig, 1974), this activity can synergized too as anti-
infective in UTI, increasing bacterial clearance.      
6. Approach from nature in antibacterial research 
Science development has explained several host-bacteria interactions and ways to rationally 
manage them. However, there is too much knowledge to acquire in this sense, but certainly 
these natural signalling mechanisms among microbes and their environment, including 
hosts, is rendering new clinical strategies and drug candidates. It is noteworthy how this 
kind of interaction is present in newborn mammals and during their span life. Food is 
something more than a mere matrix containing nutrients; starting from microbiota, human 
feeding has also coevolved with diverse biological niches.   
Antiadhesive properties of human milk oligosaccharides in relation to pathogenic bacteria 
are remarkable. They show to be effective inhibitors of adhesion of gastric and uroepithelial 
bacterial pathogens in vitro and in vivo, and prevent diarrhoea in infants (Bavington & Page, 
2005; Mårild et al., 2004; Ofek et al., 2003).  
Carbohydrate compounds are usual in food stuff, but they are not only important to supply 
energy; recently, it is known that in several ways they are involved in a microorganism 
molecular mechanism of adhesion, invasion, and infection. Glycoproteins (lectins) and a 
broad range of non-nutrient components of food plants (phytochemicals) can also be active 
in this way. 
Before vertebrates appeared, microorganisms and plants were part of the whole system of 
Nature. Plant phytochemicals are part of the pool of signals in food plant that deal with the 
microbe world. Plants that act against pathogens by a non-cidal mechanism are selected by 
Nature; but also culturally, humans have selected them as safe food plants, medicinal plants, 
or both at once. In the last decades, borders between food and medicine are disappearing, 
i.e. functional food. It is not surprising that most of them were always there, but now they 
are new products. Gastrointestinal tract and genito-urinary system are plenty of 
microorganism receptors and plant origin compounds receptors, thus dietary patterns or 
herbal products can probably promote a first barrier defence avoiding pathogen virulence 
factors like QS, fimbriae, or toxins.   
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Ethnobotany of antimicrobial food or medicinal plants can be corroborated by new 
antivirulence factor target techniques and other modern bioassays. Novel antimicrobial 
activities like antiadhesion effect could provide tools to eliminate or decrease virulence of 
infections that, in spite of quemotherapy advances, seem to become more inflexible 
microorganisms.   
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